Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sinan Mersin"'
Autor:
Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen, Mehmet Baysal, Vildan Gürsoy, Esra Yıldızhan, Serkan Güven, Tarık Ercan, Tayfun Elibol, Sinan Mersin, Eylem Genç, Eren Arslan Davulcu, Volkan Karakuş, Nergiz Erkut, Gürsel Güneş, Reyhan Diz Küçükkaya, Ahmet Emre Eşkazan
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 26-36 (2024)
Objective: In this study, we investigated the effects of calreticulin (CALR) and JAK2V617F mutational status on clinical course and disease outcomes in Turkish patients with essential thrombocythemia (ET). Materials and Methods: Seventeen centers fr
Externí odkaz:
https://doaj.org/article/ab5f757b27aa42b59fc159ec0b70c9e6
Autor:
Mehmet Baysal, Pusem Patir, Vildan Gursoy, Rafiye Çiftçiler, Ufuk Demirci, Deniz Ozmen, Zehra Narli Ozdemir, Yildiz Ipek, Emine Eylem Genc, Sinan Mersin, Serkan Guven, Elif Gulsum Umit, Volkan Karakus, Nergiz Erkut, Reyhan Diz Kucukkya, Ahmet Emre Eskazan
Publikováno v:
HemaSphere, Vol 7, p e22350da (2023)
Externí odkaz:
https://doaj.org/article/58f41a69cda04c72a449ee44206b87b6
Autor:
Sinan Mersin, Ayfer Gedük, Özgür Mehtap, Pınar Tarkun, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün, Emel Merve Yenihayat, Hayrunnisa Albayrak, Abdullah Hacıhanefioğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 3, Pp 211-217 (2021)
Objective: Constantly increasing health expenditures lead use of generic molecules and generics of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects and reliability of gener
Externí odkaz:
https://doaj.org/article/b5e4e5205dd44c599fbe6cbff037820b
Autor:
Ayfer Geduk¹, Berrin Oztas, Baldan Huri Eryılmaz, Esra Terzi Demirsoy, Meral U. Menguc, Serkan Unal, Sinan Mersin, Merve Gokcen Polat, Kemal Aygun, Emel Merve Yenihayat, Hayrunnisa Albayrak, Hasim Atakan Erol, Sibel Balcı, Ozgur Mehtap¹, Pinar Tarkun¹, Abdullah Hacihanefioglu¹
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 39:220-227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23780e74b20ca703f553f0232c67cf14
https://doi.org/10.1007/s12288-022-01574-6
https://doi.org/10.1007/s12288-022-01574-6
Autor:
Ayfer Geduk, Berrin Oztas, Baldan Huri Eryılmaz, Esra Terzi Demirsoy, Meral U. Menguc, Serkan Unal, Sinan Mersin, Merve Gokcen Polat, Kemal Aygun, Emel Merve Yenihayat, Hayrunnisa Albayrak, Hasim Atakan Erol, Sibel Balcı, Ozgur Mehtap, Pinar Tarkun, Abdullah Hacihanefioglu
Publikováno v:
Indian J Hematol Blood Transfus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f46366bd2d2bf20a437f8d687a18e9
https://europepmc.org/articles/PMC10247911/
https://europepmc.org/articles/PMC10247911/
Autor:
Ayfer Gedük, Emel Merve Yenihayat, Merve Gökçen Polat, Serkan Ünal, Pinar Tarkun, Abdullah Hacıhanifioğlu, Kemal Aygün, Sinan Mersin, Hayrunnisa Albayrak, Özgür Mehtap
Publikováno v:
Turkish Journal of Hematology
Constantly increasing health expenditures lead to the use of generic molecules and generic versions of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects, and reliability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4fe4fef39a074f26f078e3c45544fb
https://doi.org/10.4274/tjh.galenos.2021.2020.0555
https://doi.org/10.4274/tjh.galenos.2021.2020.0555
Autor:
Emel Merve Yenihayat, Tayfur Toptas, Merve Gökçen Polat, Ayfer Gedük, Sinan Mersin, Özgür Mehtap, Gozde Daglioz Gorur, Pinar Tarkun, Meral Uluköylü Mengüç, Şeyma Şumnu, Abdullah Hacıhanifioğlu, Hayrunnisa Albayrak, Serkan Ünal, Kemal Aygün
Publikováno v:
International journal of laboratory hematologyREFERENCES. 43(4)
INTRODUCTION Hodgkin lymphoma (HL) is unusual among malignancies, with inflammation playing such a prominent role in its pathogenesis. S100A8/A9 (calprotectin) is a heterodimeric protein, which has a role in the inflammatory response and oncogenesis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce82018e8c7e3a4965b67f766e5f2487
https://pubmed.ncbi.nlm.nih.gov/33904653
https://pubmed.ncbi.nlm.nih.gov/33904653
Autor:
Abdullah Hacihanefioğlu, Sinan Mersin, Pinar Tarkun, Elif Birtaş Ateşoğlu, Meral Uluköylü Mengüç, Gülçin Gacar, Esra Terzi Demirsoy, Özgür Mehtap, Serkan Ünal, Tülin Burhanoğlu, Ayfer Gedük
Publikováno v:
Acibadem Universitesi Saglik Bilimleri Dergisi. 12
Amac:Calismamizda, kronik lenfositik losemide (KLL) programli hucre olumu 1 (PD-1) ve programli hucre olumu ligandi 1 (PD-L1) ekspresyon duzeylerinin belirlenmesi ve prognoz uzerine etkilerinin degerlendirilmesi amaclandi. Hastalar ve Yontem:Klinigim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1e158630b151cd627eb3ad079636708
https://doi.org/10.31067/acusaglik.850893
https://doi.org/10.31067/acusaglik.850893
Autor:
Basol Canbakan, Gül Gürsoy, Eray Atalay, Merve Erat, Ozgur Merhametsiz, Sinan Mersin, Sengül Üçer, Canan Yazıcı, Serkan Akturk, Halil İbrahim Erdoğdu, Orhan Yücel, Can Öner
Publikováno v:
Clinical and Experimental Nephrology. 23:530-536
In hemodialysis patients Hepatitis B virus (HBV) infection is one of the problems. Because of HBV vaccine response is lower than in the general population, in this study it is aimed to determine the factors that may cause inadequate HBV vaccine respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e59b28dce00dc809cced9eb38757866
https://doi.org/10.1007/s10157-018-1676-x
https://doi.org/10.1007/s10157-018-1676-x
Autor:
Meral Uluköylü Mengüç, Özgür Mehtap, Elif Birtas Atesoglu, Pinar Tarkun, Sinan Mersin, Serkan Ünal, Ayfer Gedük, Abdullah Hacihanefioglu
Publikováno v:
Volume: 10, Issue: 3 224-229
Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
Amaç: Akut lenfositik lösemi tüm yaş gruplarında görülebilen, çocukluk yaşlarında tedavi başarısı yüksek iken ileri yaş grubunda tedavi başarısının düşük, sağ kalımın az olduğu bir hastalıktır. Yaşlı hasta grubunda eşli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47f0c64cf376356913390782b8a823a
https://dergipark.org.tr/tr/pub/sdusbed/issue/48870/497315
https://dergipark.org.tr/tr/pub/sdusbed/issue/48870/497315